Title : AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies.

Pub. Date : 1996

PMID : 8612303






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies. nolatrexed thymidylate synthase Mus musculus
2 3,4-Dihydro-2-amino-6 methyl-4-oxo-5-(4-pyridylthio)-quinazoline dihydrochloride (AG337) is a water-soluble, lipophilic inhibitor of thymidylate synthase (TS) designed using X-ray structure - based methodologies to interact at the folate cofactor binding site of the enzyme. nolatrexed thymidylate synthase Mus musculus
3 3,4-Dihydro-2-amino-6 methyl-4-oxo-5-(4-pyridylthio)-quinazoline dihydrochloride (AG337) is a water-soluble, lipophilic inhibitor of thymidylate synthase (TS) designed using X-ray structure - based methodologies to interact at the folate cofactor binding site of the enzyme. nolatrexed thymidylate synthase Mus musculus
4 3,4-Dihydro-2-amino-6 methyl-4-oxo-5-(4-pyridylthio)-quinazoline dihydrochloride (AG337) is a water-soluble, lipophilic inhibitor of thymidylate synthase (TS) designed using X-ray structure - based methodologies to interact at the folate cofactor binding site of the enzyme. nolatrexed thymidylate synthase Mus musculus
5 3,4-Dihydro-2-amino-6 methyl-4-oxo-5-(4-pyridylthio)-quinazoline dihydrochloride (AG337) is a water-soluble, lipophilic inhibitor of thymidylate synthase (TS) designed using X-ray structure - based methodologies to interact at the folate cofactor binding site of the enzyme. nolatrexed thymidylate synthase Mus musculus